Other Neurological disorders
We are continuously expanding our iPSC library and utilize our dedicated CRISPR facility to develop novel disease lines. Combined with our advanced functional assays, we enable the in-depth study of disease mechanisms and the evaluation of therapeutic efficacy across a wide range of neurological conditions.
Model characterization
We offer high-resolution molecular, morphological, and functional validation to ensure your models are research-ready:
- Neuronal network activity measurements
- Synaptic connectivity and neurotransmission
- Patch clamp electrophysiology and MEA
- Neurite growth and degeneration assays
- Mitochondrial and organelle transport dynamics
- Protein aggregation, biochemistry (mRNA/protein) and pathology assays
- mRNA and protein biochemistry
This deep phenotypic characterization allows for robust benchmarking of disease phenotypes and precise quantitative assessment of therapeutic rescue.
Partner with us: We invite you to discuss your specific research requirements or custom disorder models with our team.
